# EDGAR Filing Document

**Accession Number:** 0001166152
**File Stem:** 0001011438-25-000336
**Filing Date:** 2025-6
**Character Count:** 37546
**Document Hash:** 10375bad6a4cb1aeb1afa1df80b5c345
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001011438-25-000336.hdr.sgml**: 20250609

**ACCESSION NUMBER**: 0001011438-25-000336

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250609

**DATE AS OF CHANGE**: 20250609

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Performant Healthcare Inc
- **CENTRAL INDEX KEY:** 0001550695
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MISCELLANEOUS BUSINESS SERVICES [7380]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 200484934
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-87238
- **FILM NUMBER:** 251035461

**BUSINESS ADDRESS:**
- **STREET 1:** 900 SOUTH PINE ISLAND ROAD
- **STREET 2:** SUITE 150
- **CITY:** PLANTATION
- **STATE:** FL
- **ZIP:** 33324
- **BUSINESS PHONE:** 925-960-4800

**MAIL ADDRESS:**
- **STREET 1:** 4309 HACIENDA DR
- **STREET 2:** SUITE 110
- **CITY:** PLEASANTON
- **STATE:** CA
- **ZIP:** 94588

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Performant Financial Corp
- **DATE OF NAME CHANGE:** 20120523
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.
- **CENTRAL INDEX KEY:** 0001166152

**ORGANIZATION NAME:**
- **EIN:** 731554000
- **STATE OF INCORPORATION:** OK
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**BUSINESS ADDRESS:**
- **STREET 1:** 1924 S UTICA AVE
- **STREET 2:** SUITE 1120
- **CITY:** TULSA
- **STATE:** OK
- **ZIP:** 74104-6429
- **BUSINESS PHONE:** 918-747-3412

**MAIL ADDRESS:**
- **STREET 1:** 1924 S UTICA AVE
- **STREET 2:** SUITE 1120
- **CITY:** TULSA
- **STATE:** OK
- **ZIP:** 74104-6429

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PRESCOTT GROUP CAPITAL MANAGEMENT LLC
- **DATE OF NAME CHANGE:** 20020128

## Exhibit 99.1

<u>CONFIDENTIALITY AGREEMENT</u>

THIS AGREEMENT is entered into as of June 4, 2025, by and between **Performant Healthcare, Inc.**, a Delaware corporation (the "Company"), and **Prescott Group Capital Management, LLC** (the "Investor"), for itself and its affiliates.

The parties are interested in an exchange of confidential information relating to the business operations of the Company, including, without limitation, information about the Company's business, operations, products, financial results, financial projections, strategic plans, marketing information, business plans, vendors or customers (current or potential), and the existence and nature of this Agreement and the exchange of information hereunder between the parties (the "Confidential Information"). Information shall include information provided by the Company to the Investor in whatever form or medium (whether orally or in written or other tangible form).

In view of the above-stated intentions, the parties agree as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. The Company agrees to disclose the Confidential Information to the Investor in connection with the Investor's evaluation of the current and proposed business operations of the Company (the "Business").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. The Investor agrees that it will not disclose any Confidential Information received from the Company to third parties other than to its general partners, directors, officers, employees, attorneys, accountants, bankers, financial advisors or consultants (collectively, Representatives") who need to know such information for the sole purpose of evaluating the Business (it being understood that such Representatives shall be informed of the confidential nature of such Confidential Information, shall be delivered a copy of this Agreement, and shall agree to abide by the terms hereof), and the Investor agrees not to use any of such Information at any time except for the purposes of such evaluation; provided, however, the Investor shall have no liability to the Company with respect to use, or disclosure to others not parties to this Agreement, of such information as the Investor can establish by written documentation to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) have been publicly known;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) have become publicly known, without fault on the part of Investor, subsequent to disclosure by the Company of such Confidential Information to the Investor;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) have been otherwise known by the Investor prior to communication by the Company to the Investor of such Confidential Information;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) have been received by the Investor at any time from a source other than the Company lawfully having possession of such information; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) have been independently developed by the Investor without use of such Confidential Information.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Subject to the terms and conditions described elsewhere in this Agreement, the Investor shall not use any Confidential Information of the Company that may be material, non-public information within the meaning of Section 10(b) of the Securities Exchange Act of 1934 for purposes of trading in the Company's securities, nor, in cognizance of Regulation FD promulgated by the Securities and Exchange Commission, divulge such Confidential Information to anyone unaffiliated with the Investor.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. In the event that the Investor or any of its Representatives are requested or required (by deposition, interrogatories, requests for information or documents in legal proceedings, subpoena, civil investigative demand or other similar process) to disclose any of the Confidential Information, the Investor shall provide the Company with prompt written notice of any such request or requirement so that the Company may seek a protective order or other appropriate remedy and/or waive compliance with the provisions of this Agreement. If, in the absence of a protective order or other remedy or the receipt of a waiver by the Company, the Investor or any of the Investor's Representatives are nonetheless, in the opinion of the Investor's counsel, legally compelled to disclose Confidential Information or else stand liable for contempt or suffer other censure or penalty, the Investor or the Investor's Representative may, without liability hereunder, disclose only that portion of the Confidential Information which such counsel advises the Investor is legally required to be disclosed, provided that the Investor exercises efforts, at the Company's expense, to preserve the confidentiality of the Confidential Information, including, without limitation, by cooperating with the Company to obtain an appropriate protective order or other reliable assurance that confidential treatment will be accorded the Confidential Information. Notwithstanding the foregoing, notice to the Company shall not be required where disclosure is made (i) in response to a request by a regulatory or self-regulatory authority or (ii) in connection with a routine audit or examination by a bank examiner or auditor and such audit or examination does not reference the Company or this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. Upon termination of this Agreement, the Investor shall promptly return to the Company or, to the extent legally permissible, destroy or delete all Confidential Information, any copies thereof and any materials prepared by Investor based upon or containing the Confidential Information, and, in either case, confirm in writing to the Company that all such material has been destroyed or deleted or returned, as applicable, in compliance with this Agreement; provided that the Investor may maintain copies of the Confidential Information to the extent required by applicable law, regulation or court or governmental order; and provided further that a hard copy of the Information may be retained in a confidential file by the Investor's legal department in accordance with its document retention policy. Notwithstanding the return or destruction of the Confidential Information and such related material, the Investor and the Investor's Representatives will continue to be bound by the Investor's obligations of confidentiality and other obligations hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. This Agreement shall not be construed to grant any license or other rights except as specified herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. This Agreement may not be assigned by a party hereto.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8. Each party warrants that it believes that it has the right to enter into and to perform its obligations hereunder without any breach of its obligations to others. The Company makes no other warranty relating to the Confidential Information and the use to be made thereof by the Investor and disclaims all implied warranties. The Investor agrees that neither the Company nor any of its Representatives shall have any liability to the Investor or any of its Representatives relating to or resulting from the use of the Confidential Information.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9. The Investor acknowledges that monetary damages may not be a sufficient remedy for unauthorized use or disclosure of Confidential Information in breach of this Agreement and that the Company shall be entitled, without waiving any other rights or remedies, to seek such injunctive or equitable relief as may be deemed proper by a court of competent jurisdiction.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10. No change, modification, extension, termination or waiver of this Agreement, or any of the provisions herein contained, shall be valid unless made in writing and signed by duly authorized representatives of the parties hereto.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11. This Agreement may be terminated at any time by either party by written notice to the other party, which may be provided in electronic form. Upon any such termination, all rights, restrictions and obligations under this Agreement shall remain in force and effect for a period of six (6) months following the date upon which notice of termination is delivered.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13. This Agreement shall be governed by and construed in accordance with the laws of the State of California.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14. This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15. Investor agrees that for a period of 12 months from the date of this Agreement, neither you nor your ultimate parent entity nor any of its controlled affiliates will, unless specifically invited in writing by the board of directors of the Company, directly or indirectly, in any manner (your obligations pursuant to this paragraph being, the "Standstill"): (i) acquire, offer or propose to acquire, solicit an offer to sell or agree to acquire, alone or in concert with others, by purchase or otherwise, any direct or indirect beneficial interest in any voting securities or direct or indirect rights, warrants or options to acquire, or securities convertible into or exchangeable for, any voting securities of the Company; (ii) make, or in any way participate in, alone or in concert with others, any "solicitation" of "proxies" to vote (as such terms are used in the proxy rules of the Securities and Exchange Commission promulgated pursuant to Section 14 of the Securities Exchange Act of 1934, as amended (the "Exchange Act")), whether subject to or exempt from the proxy rules, or seek to advise or intentionally influence any person or entity with respect to the voting of any voting securities of the Company; (iii) form, join or any way participate in a "group" within the meaning of Section 13(d)(3) of the Exchange Act with respect to any voting securities of the Company; (iv) acquire, offer to acquire or agree to acquire, alone or in concert with others, by purchase, exchange or otherwise, (a) except in the ordinary course of business, any of the assets, tangible and intangible, of the Company or any of its subsidiaries or (b) direct or indirect warrants, options or other similar rights to acquire any assets of the Company or any of its subsidiaries; (v) arrange, or in any way participate, directly or indirectly, in any financing for the purchase of any voting securities or securities convertible or exchangeable into or exercisable for any voting securities of the Company or assets of the Company or any of its subsidiaries; (vi) alone or in concert with others, propose to the Company or any of its affiliates or any of their respective shareholders or unitholders any merger, business combination, consolidation, sale, restructuring, reorganization, recapitalization or other transaction involving the Company or otherwise seek, alone or in concert with others, to control, change or influence the management or board of directors of the Company or nominate any person as a director who is not nominated by the then incumbent directors, or propose any matter to be voted upon by the shareholders of the Company or any of its affiliates; (vii) make any request or proposal to amend, waive or terminate any provision of this Standstill or seek permission to or make any public announcement with respect to any provision of this Standstill; or (viii) announce an intention to do, or enter into any arrangement or understanding with others to do, any of the actions restricted or prohibited under clauses (i) through (vii) of this Standstill, or knowingly take any action that is intended to cause the Company to be required under applicable law to make a public announcement regarding any of the matters referred to in clauses (i) through (vii) of this Standstill; provided that you shall be permitted to make a proposal to take any of the actions referred to in clauses (i) through (vii) above directly to the Chief Executive Officer or Board of Directors of the Company in a manner not intended to cause the Company to be required under applicable law to make a public announcement regarding such proposal. This Standstill shall terminate and be of no further force or effect at such time as the Company (1) enters into a definitive agreement with any person or "group" (within the meaning of Section 13(d)(3)) of the Exchange Act) pursuant to which such person or "group" would, upon consummation of the transactions contemplated thereby, acquire, or any person or "group" acquires, beneficial ownership of a majority of the Company's outstanding voting securities or all or a majority of the Company's assets or (2) publicly announces its intention to enter into such a definitive agreement with any such person or "group.

[*Signature page to follow*] <br>

------

ACCEPTED AND AGREED TO:

PERFORMANT HEALTHCARE, INC.

By:&nbsp;&nbsp;&nbsp;&nbsp; <u>/s/ Simeon Kohl</u><br> Name: Simeon Kohl<br> Title: CEO<br>

PRESCOTT GROUP CAPITAL MANAGEMENT, LLC

By:&nbsp;&nbsp;&nbsp;&nbsp; <u>/s/ Phil Frohlich</u><br> Name: Phil Frohlich<br> Title: Manager

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 6)**

**Performant Healthcare, Inc.**

*(Name of Issuer)*

**Common Stock, $0.0001 par value per share**

*(Title of Class of Securities)*

**71377E105**

*(CUSIP Number)*

**Phil Frohlich**<br>1924 South Utica Ave., Suite #1120<br>Tulsa OK 74104-6429<br>(918) 747-3412

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**06/05/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **71377E105** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Prescott Group Capital Management, L.L.C.** | Name of reporting person<br>**Prescott Group Capital Management, L.L.C.** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**OKLAHOMA** | Citizenship or place of organization<br>**OKLAHOMA** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**15793291.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**15793291.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**15793291.00** | Aggregate amount beneficially owned by each reporting person<br>**15793291.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**20.2%** | Percent of class represented by amount in Row (11)<br>**20.2%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IA** | Type of Reporting Person (See Instructions)<br>**IA** | |

---

| **CUSIP No.** | **71377E105** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Prescott Group Aggressive Small Cap, L.P.** | Name of reporting person<br>**Prescott Group Aggressive Small Cap, L.P.** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**OKLAHOMA** | Citizenship or place of organization<br>**OKLAHOMA** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**15793291.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**15793291.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**15793291.00** | Aggregate amount beneficially owned by each reporting person<br>**15793291.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**20.2%** | Percent of class represented by amount in Row (11)<br>**20.2%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

| **CUSIP No.** | **71377E105** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Prescott Group Aggressive Small Cap II, L.P.** | Name of reporting person<br>**Prescott Group Aggressive Small Cap II, L.P.** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**OKLAHOMA** | Citizenship or place of organization<br>**OKLAHOMA** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**15793291.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**15793291.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**15793291.00** | Aggregate amount beneficially owned by each reporting person<br>**15793291.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**20.2%** | Percent of class represented by amount in Row (11)<br>**20.2%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

| **CUSIP No.** | **71377E105** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Prescott Group Aggressive Small Cap Master Fund, G.P.** | Name of reporting person<br>**Prescott Group Aggressive Small Cap Master Fund, G.P.** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**OKLAHOMA** | Citizenship or place of organization<br>**OKLAHOMA** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**15793291.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**15793291.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**15793291.00** | Aggregate amount beneficially owned by each reporting person<br>**15793291.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**20.2%** | Percent of class represented by amount in Row (11)<br>**20.2%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

| **CUSIP No.** | **71377E105** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Phil Frohlich** | Name of reporting person<br>**Phil Frohlich** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**15793291.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**15793291.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**15793291.00** | Aggregate amount beneficially owned by each reporting person<br>**15793291.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**20.2%** | Percent of class represented by amount in Row (11)<br>**20.2%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock, $0.0001 par value per share

**(b) Name of Issuer:**
Performant Healthcare, Inc.

**(c) Address of Issuer's Principal Executive Offices:**
900 South Pine Island Road, Suite 150, Plantation, FL, 33324

The following constitutes Amendment No. 6 ("Amendment No. 6") to the Schedule 13D filed with the Securities and Exchange Commission ("SEC") by Prescott Group Capital Management, L.L.C., an Oklahoma limited liability company ("Prescott Capital"), Prescott Group Aggressive Small Cap, L.P., an Oklahoma limited partnership ("Prescott Small Cap"), Prescott Group Aggressive Small Cap II, L.P., an Oklahoma limited partnership ("Prescott Small Cap II", and, together with Prescott Small Cap, the "Small Cap Funds"), Prescott Group Aggressive Small Cap Master Fund, G.P., an Oklahoma general partnership ("Master Fund") and Phil Frohlich, the principal of Prescott Capital, relating to Common Stock, par value $0.0001 per share (the "Common Stock"), of Performant Healthcare, Inc. (f/k/a Performant Financial Corporation), a Delaware corporation (the "Issuer") on March 26, 2020, as amended by Amendment No. 1 filed on October 26, 2020, Amendment No. 2 filed on June 4, 2021, Amendment No. 3 filed on October 7, 2021, Amendment No. 4 filed on January 25, 2022, and Amendment No. 5 filed on March 20, 2023.

This Amendment No. 6 relates to shares of Common Stock of the Issuer held in the account of the Master Fund, of which the Small Cap Funds are general partners. Prescott Capital serves as the general partner and investment manager of the Small Cap Funds and may direct the Small Cap Funds, the general partners of the Master Fund, to direct the vote and disposition of the 15,793,291 shares of Common Stock held by the Master Fund. As the principal of Prescott Capital, Mr. Frohlich may direct the vote and disposition of the 15,793,291 shares of Common Stock held by the Master Fund.

All capitalized terms contained herein but not otherwise defined shall have the meanings ascribed to such terms in the Schedule 13D, as amended. Information given in response to each item shall be deemed incorporated by reference in all other items, as applicable.

**Item 4. Purpose of Transaction**

Item 4 of Schedule 13D is supplemented and superseded, as the case may be, as follows:

On June 5, 2025, Prescott Capital entered into a confidentiality agreement with the Issuer (the "Confidentiality Agreement"), dated as of June 4, 2025, pursuant to which the Issuer agreed to provide certain information in connection with Prescott Capital's evaluation of the Issuer's current and proposed business operations. In addition, the Confidentiality Agreement places certain "standstill" obligations (the "Standstill") on Prescott Capital and its affiliates for a period of 12 months from the date of the Confidentiality Agreement. Pursuant to the Standstill, unless specifically invited in writing by the Issuer's Board of Directors (the "Board"), Prescott Capital, for itself and its affiliates agreed not to: (i) acquire, offer or propose to acquire, solicit an offer to sell or agree to acquire, alone or in concert with others, any direct or indirect beneficial interest in any voting securities of the Issuer or any rights, warrants or options to acquire, or securities convertible into or exchangeable for voting securities of the Issuer; (ii) make, or in any way participate in, any solicitation of proxies of the Issuer or seek to influence the vote of any Issuer securities; (iii) form, join or participate in a "group" with respect to voting securities of the Issuer; (iv) acquire, offer to acquire or agree to acquire, alone or in concert with others, any assets of the Issuer or any of its subsidiaries or rights, warrants or options to acquire assets of the Issuer or any of its subsidiaries except in the ordinary course of business; (v) arrange, or in any way participate, directly or indirectly, in any financing for the purchase of any voting securities or securities convertible or exchangeable into or exercisable for any voting securities of the Issuer or assets of the Issuer or any of its subsidiaries; (vi) propose, either alone or in concert with others, to the Issuer or any of its affiliates or any of their respective shareholders or unitholders any merger, business combination, consolidation, sale, restructuring, reorganization, recapitalization or other transaction involving the Issuer or otherwise seek, alone or in concert with others, to control, change or influence the management of the Board or nominate any person as a director who is not nominated by the then incumbent directors, or propose any matter to be voted upon by the shareholders of the Issuer or any of its affiliates; (vii) make any request or proposal to amend, waive or terminate any provisions of the Standstill; or (viii) announce an intention to do, or enter into any arrangement or understanding with others to do, any of the actions restricted or prohibited by the Standstill. The Standstill would also terminate if the Issuer enters into a definitive agreement pursuant to which any person or group would acquire beneficial ownership of a majority of the Issuer's outstanding voting securities or all or a majority of the Issuer's assets or the Issuer announces its intention to enter into such a definitive agreement with any person or group. 

The Confidentiality Agreement may be terminated at any time by either party by written notice to the other party. Upon any such termination, all rights, restrictions and obligations under the Confidentiality Agreement will remain in force and effect for a period of six months following the date upon which notice of termination is delivered.

The foregoing description of the Confidentiality Agreement is qualified in its entirety by reference to the full text of the Confidentiality Agreement, which is filed as Exhibit 99.1 and is incorporated herein by reference.

The Reporting Persons intend to review their investment in the Issuer on a continuing basis and may from time to time and at any time in the future depending on various factors, including, without limitation, the Issuer's financial position and strategic direction, actions taken by the Issuer's Board, price levels of the Issuer's securities, other investment opportunities available to the Reporting Persons, conditions in the securities market and general economic and industry conditions, take such actions with respect to the investment in the Issuer as they deem appropriate. Subject to the limitations of the terms of the Confidentiality Agreement, these actions may include: (i) acquiring additional shares of Common Stock and/or other equity, debt, notes, other securities, or derivative or other instruments that are based upon or relate to the value of securities of the Issuer (collectively, "Securities") in the open market or otherwise; (ii) disposing of any or all of their Securities in the open market or otherwise; (iii) engaging in any hedging or similar transactions with respect to the Securities; or (iv) proposing or considering one or more of the actions described in subsections (a) through (j) of Item 4 of Schedule 13D.

**Item 5. Interest in Securities of the Issuer**

**(a)**
Items 11 and 13 of each of the cover pages of this Schedule 13D are incorporated herein by reference. Such information is based on 78,308,640 shares of Common Stock outstanding as of May 8, 2025, as reported in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on May 9, 2025.

As of 9:00 a.m., New York City time, on June 9, 2025, the Master Fund directly held and beneficially owned 15,793,291 shares of Common Stock, representing approximately 20.2% of the outstanding Common Stock. As general partners of the Master Fund, the Small Cap Funds may be deemed to beneficially own the shares of Common Stock held by the Master Fund. As the general partner of the Small Cap Funds, Prescott Capital may also be deemed to beneficially own the shares of Common Stock held by the Master Fund. As managing member of Prescott Capital, Phil Frohlich may be deemed to beneficially own the shares of Common Stock held by the Master Fund.

**(b)**
Items 7 through 10 of each of the cover pages of this Schedule 13D are incorporated herein by reference.

**(c)**
There have been no transactions by the Reporting Persons in the class of securities reported on that were effected within the past 60 days.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

Item 6 of Schedule 13D is supplemented and superseded, as the case may be, as follows:

The information in Item 4 is incorporated herein by reference.

The Confidentiality Agreement is incorporated by reference as Exhibit 99.1 and is incorporated herein by reference.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Prescott Group Capital Management, L.L.C.

**Signature:** /s/ Phil Frohlich

**Name/Title:** Phil Frohlich / Managing Member

**Date:** 06/09/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Prescott Group Aggressive Small Cap, L.P.

**Signature:** /s/ Phil Frohlich

**Name/Title:** Phil Frohlich / Managing Member of Prescott Group Capital Management, L.L.C., its general partner

**Date:** 06/09/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Prescott Group Aggressive Small Cap II, L.P.

**Signature:** /s/ Phil Frohlich

**Name/Title:** Phil Frohlich / Managing Member of Prescott Group Capital Management, L.L.C., its general partner

**Date:** 06/09/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Prescott Group Aggressive Small Cap Master Fund, G.P.

**Signature:** /s/ Phil Frohlich

**Name/Title:** See Comments

**Date:** 06/09/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Phil Frohlich

**Signature:** /s/ Phil Frohlich

**Name/Title:** Phil Frohlich / Self

**Date:** 06/09/2025